Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

Operator: Greetings. And welcome to the Tenon Medical Fourth Quarter and Full Year 2024 Financial Results and Corporate ...

National Development Bank PLC (NDB) conducted its Investor and Analysts Earnings Call on 12th of March, following the release ...

On October 17, 2024, the Corporation voluntarily repaid the outstanding principal on both the Fixed Rate Construction Facility and the Bank Term Facility #1, for a total principal repayment of $49.9 ...

Q4 2024 Results Conference Call March 20, 2025 9:00 AM ETCompany ParticipantsStefanie Zimmermann - Vice President, ...

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today reports financial results for the fourth quarter and year ended ...

Operating expenses in the fourth quarter of 2024 were $2.9 million compared to $1.6 million for the same period in 2023. The increase was primarily due to an increase in share compensation expense ...

PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology ...

Revenues Increased 21% and Gross Profit Increased 56% Generated Fourth Quarter Adjusted EBITDA of $1.1 Million ADT Acquisition ...

Power Corporation of Canada (Power Corporation or the Corporation) (TSX: POW) (TSX: POW.PR.E) today reported earnings results for the three and twelve months ended December 31, 2024.

March 19, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for ...

TRUSense GatewayTM Progress: The Company announced the certification of the TRUSense Fiber Gateway in April 2024, the TRUSense Ethernet Gateway in July 2024, and the TRUSense Cellular Gateway in ...